Identification of biallelic EXTL3 mutations in a novel type of spondylo-epi-metaphyseal dysplasia

dc.contributor.authorGuo, Long
dc.contributor.authorElcioglu, Nursel H.
dc.contributor.authorMizumoto, Shuji
dc.contributor.authorWang, Zheng
dc.contributor.authorNoyan, Bilge
dc.contributor.authorAlbayrak, Hatice M.
dc.contributor.authorIkegawa, Shiro
dc.date.accessioned2026-02-06T18:43:33Z
dc.date.issued2017
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractSpondylo-epi-metaphyseal dysplasia (SEMD) is a group of inherited skeletal diseases characterized by the anomalies in spine, epiphyses and metaphyses. SEMD is highly heterogeneous and 420 distinct entities have been identified. Here we describe a novel type of SEMD in two unrelated Turkish patients who presented with severe platyspondyly, kyphoscoliosis, pelvic distortion, constriction of the proximal femora and brachydactyly. Although these phenotypes overlap considerably with some known SEMDs, they had a novel causal gene, exostosin-like glycosyltransferase 3 (EXTL3), that encodes a glycosyltransferase involved in the synthesis of heparin and heparan sulfate. The EXTL3 mutation identified in the patients was a homozygous missense mutation (c. 953C>T) that caused a substitution in a highly conserved amino acid (p.P318L). The enzyme activity of the mutant EXTL3 protein was significantly decreased compared to the wild-type protein. Both patients had spinal cord compression at the cranio-vertebral junction and multiple liver cysts since early infancy. One of the patients showed severe immunodeficiency, which is considered non-fortuitous association. Our findings would help define a novel type of SEMD caused by EXTL3 mutations.
dc.description.sponsorshipJapan Agency For Medical Research and Development (AMED) [14525125]; Japan Society for the Promotion of Science, Japan [16K08251]; Nakatomi Foundation; Grants-in-Aid for Scientific Research [17K16710, 15K07951, 16H05357, 16K08251] Funding Source: KAKEN
dc.description.sponsorshipWe thank the patients and their families for their help to the study. This study was supported in part by research grants from Japan Agency For Medical Research and Development (AMED; contract No 14525125), by a Grant-in-Aid for Scientific Research (C) 16K08251 (to SM) from the Japan Society for the Promotion of Science, Japan, and by the Nakatomi Foundation (to SM).
dc.identifier.doi10.1038/jhg.2017.38
dc.identifier.endpage801
dc.identifier.issn1434-5161
dc.identifier.issn1435-232X
dc.identifier.issue8
dc.identifier.orcid0000-0002-4641-1505
dc.identifier.orcid0000-0002-9660-6941
dc.identifier.orcid0000-0001-5624-3878
dc.identifier.pmid28331220
dc.identifier.scopus2-s2.0-85021310767
dc.identifier.scopusqualityQ2
dc.identifier.startpage797
dc.identifier.urihttps://doi.org/10.1038/jhg.2017.38
dc.identifier.urihttps://hdl.handle.net/11129/13670
dc.identifier.volume62
dc.identifier.wosWOS:000406281300011
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherNature Publishing Group
dc.relation.ispartofJournal of Human Genetics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260204
dc.subjectHeparan-Sulfate Proteoglycans
dc.subjectMucocutaneous Candidiasis
dc.subjectChondroitin Sulfate
dc.subjectSkeletal Dysplasia
dc.subjectDifferentiation
dc.subjectGrowth
dc.subjectDelay
dc.subjectBfgf
dc.subjectFgf
dc.titleIdentification of biallelic EXTL3 mutations in a novel type of spondylo-epi-metaphyseal dysplasia
dc.typeArticle

Files